Industry News

The World Bank, whose 8,000 employees are housed at its headquarters in downtown Washington, is planning to relocate its back-up office and computer operations outside the District following the events of September 11. The 200,000-sf Presidents Park office facility in Herndon is under consideration. Formerly occupied by Winstar, the structure could accommodate computers and personnel in an emergency, as well as provide technical data center equipment.

Cisco Systems’ planned 10-building, 1.5-million-sf office campus in Boxborough may be enlarged by half again as much if approvals from state and town agencies are granted. An additional 500,000 sf in three buildings would be added to the Boxborough site, where three structures are half built, and four more have already been approved. The San  Jose, Calif.-based company hopes to consolidate several of its Massachusetts facilities at the Boxborough site. Move-in is anticipated in mid-2003 at the earliest.

Vanguard Group has completed construction of three 120,000-sf structures at its 300-acre campus in Malvern. The company is beginning preliminary work on an additional 2.5 million sf, with phase one construction on the proposed project starting as early as spring 2002. The multi-phased project would begin with two buildings, each 320,000 sf, on 70 acres of the company’s 250-acre Downington campus.

Allstate Corp. plans to occupy 50,030 sf at a new 70,000-sf office building under construction at Twin Oaks Office Park in North Central San Antonio. The Northbrook, Ill.-based national insurance company will be the major tenant at Two Twin Oaks, which has 67,000 sf net rental space available.

Abbot Labs, based in Illinois, is proposing to build a West Coast R&D headquarters at the former 35-acre Cargill Salt site in Redwood City. The site is adjacent to Perclose, the medical device manufacturer recently purchased by Abbott. Phase I of the one-million-sf project would accommodate approximately 500 employees in 250,000 sf of lab and office space, where the pharmaceutical and diagnostic company will expand its cardiac product line. By the end of 2002, Abbott anticipates completion of the planning, design, and review of the project.